Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatric Hematology · Diamond-Blackfan Anemia

Treatment for Diamond-Blackfan Anemia

At a Glance

Diamond-Blackfan anemia treatment often starts with steroids; children who do not respond may need regular transfusions and iron-removing medicine. A stem cell transplant can correct the anemia in selected children but has serious risks and does not remove the genetic change elsewhere in the body.

Managing Diamond-Blackfan Anemia (DBA) is a long-term commitment that evolves as your child grows. Because DBA is a genetic condition, treatment focuses on maintaining healthy oxygen levels while minimizing the side effects of medications and transfusions [1][2].

Current international guidelines, updated in 2024, emphasize a cautious, staged approach to care that prioritizes your child’s growth and organ health [1].

The First Line: Corticosteroids

For children who require treatment for anemia, corticosteroids (usually prednisone) are typically the first option explored [1][3].

  • Response Rates: While many children show an initial improvement in their red blood cell counts, a smaller percentage remain responsive to steroids over the long term [1][4].
  • Age Considerations: Doctors generally defer starting steroids until infants are about 12 months old. This balances the treatment against the risk of toxicity to the child’s growth, neurodevelopment, and metabolic health [1][2]. Infants who need treatment generally receive transfusions under specialist care.
  • Side Effects in Children: Long-term steroid use can be difficult for a growing body. Common concerns include growth impairment (short stature), weakened bones (osteoporosis), high blood sugar, and a suppressed immune system [5][6]. Guidelines recommend keeping the maintenance dose as low as possible to reduce these risks [1].

Chronic Transfusions: When Steroids Aren’t Enough

If a child does not respond to steroids, or if the side effects become too severe, they will transition to a chronic transfusion program [1][3].

  • The Target: Modern guidelines recommend keeping the “pre-transfusion” hemoglobin (the level just before the next bag of blood) between 9 and 10 g/dL [1]. This ensures the child has enough energy to grow and play normally [7].
  • The Schedule: Transfusions typically occur every 3 to 5 weeks [7].

The Necessity of Iron Chelation

Every bag of blood contains iron. Because the human body has no way to get rid of extra iron, it builds up in the heart, liver, and hormone-producing glands [8][6]. This is called iron overload, and it can be life-threatening if left untreated [3].

  • Chelation Therapy: To prevent damage, children on regular transfusions must take iron chelators—medications that grab the extra iron and help the body flush it out through urine or stool [3][9].
  • Monitoring: Iron monitoring begins early. Your doctor will use blood tests (ferritin) and specialized MRIs to measure iron levels. Cardiac T2 MRI* assesses iron in the heart, while FerriScan (R2) assesses iron in the liver. Timing depends on transfusion burden and specialist protocol [8][10].
  • Safety: While effective, common chelators like deferasirox require close monitoring of kidney function and hydration, especially during stomach illnesses [9][11].

Hematopoietic Stem Cell Transplantation (HSCT)

HSCT (a bone marrow transplant) is currently the only curative hematologic option for DBA [12]. It replaces the faulty marrow with healthy cells from a donor.

  • Who is it for?: It is usually considered for selected children who cannot tolerate steroids and are dependent on transfusions, especially if they have a “matched sibling” donor [13][14].
  • Timing Matters: Outcomes are generally best when performed at younger ages and before significant iron overload develops [13][15].
  • Weighing the Risks: While survival rates can be favorable in optimal conditions, it is a major procedure. Risks include Graft-versus-Host Disease (GVHD), severe infection, organ toxicity, infertility, and graft failure [13][15].

It is important to remember that while HSCT fixes the anemia, it does not change the underlying genetic mutation in the rest of the body. Children who have had a transplant still need lifelong follow-up to monitor for other DBA-related risks, such as certain types of cancer [16][17]. Broader follow-up for endocrine function, bone health, and psychosocial support is also essential.

Common questions in this guide

When are steroids used to treat Diamond-Blackfan anemia?
Corticosteroids, usually prednisone, are often the first treatment for children who need help with anemia. Doctors generally wait until about 12 months of age when possible because earlier use can affect growth, development, and metabolism; infants who need treatment usually receive transfusions under specialist care.
What happens if my child does not respond to steroids?
If steroids do not work or their side effects are too severe, the child may enter a regular red blood cell transfusion program. Transfusions are commonly given every 3 to 5 weeks, with a goal of keeping the hemoglobin level just before transfusion around 9 to 10 g/dL.
Why does my child need iron chelation during regular transfusions?
Each transfusion adds iron, and the body cannot remove the extra amount on its own. Iron-chelating medicine helps the body get rid of this iron and lowers the risk of damage to the heart, liver, and hormone-producing glands.
How is iron overload checked in a child with DBA?
Doctors use blood ferritin tests and specialized MRI scans to measure iron. A cardiac T2* MRI checks the heart, while a liver R2 MRI, often called FerriScan, checks the liver; the schedule depends on transfusion burden and the specialist's protocol.
When is a stem cell transplant considered for Diamond-Blackfan anemia?
A hematopoietic stem cell transplant, also called a bone marrow transplant, may be considered for selected children who depend on transfusions and cannot tolerate or respond to steroids, especially when a matched sibling donor is available. Results are generally best at younger ages and before major iron overload, but the procedure can cause serious complications such as severe infection, graft-versus-host disease in which donor cells attack the child's tissues, organ injury, infertility, or graft failure.
Does a stem cell transplant remove all effects of Diamond-Blackfan anemia?
A transplant can correct the blood-making problem, but it does not remove the genetic change from the rest of the body. Children who have a transplant still need lifelong follow-up for cancer risk, hormone function, bone health, and emotional or social support.
How are steroid side effects monitored in a child with DBA?
The care team should monitor growth, bone health, blood sugar, immune problems, and adrenal function while a child takes steroids. Doctors generally aim for the lowest maintenance dose that controls the anemia to limit long-term side effects.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my child's current age and development, are we at the point where a corticosteroid trial is appropriate?
  2. 2.What is the plan for monitoring my child’s growth, bone density, and adrenal health while they are on steroids?
  3. 3.Is my child’s pre-transfusion hemoglobin target set at 9–10 g/dL as recommended by the newest guidelines?
  4. 4.How frequently will we use MRI to check for liver and heart iron buildup, and when does iron monitoring begin?
  5. 5.If my child is considered 'steroid-refractory,' have we started the process of HLA-typing family members for a possible stem cell transplant?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.

    Wlodarski MW, Vlachos A, Farrar JE, et al.

    The Lancet. Haematology 2024; (11(5)):e368-e382 doi:10.1016/S2352-3026(24)00063-2.

    PMID: 38697731
  2. 2

    Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science.

    Bhoopalan SV, Suryaprakash S, Sharma A, Wlodarski MW

    Frontiers in oncology 2023; (13()):1236038 doi:10.3389/fonc.2023.1236038.

    PMID: 37752993
  3. 3

    Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment.

    Li H, Lodish HF, Sieff CA

    Hematology/oncology clinics of North America 2018; (32(4)):701-712 doi:10.1016/j.hoc.2018.04.005.

    PMID: 30047421
  4. 4

    Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure Registry.

    Choi YB, Mathew R, Li H, et al.

    European journal of haematology 2026; (117(1)):267-273 doi:10.1111/ejh.70187.

    PMID: 41948977
  5. 5

    Short Stature in Patients with Diamond-Blackfan Anemia: A Cross-Sectional Study.

    Wan Y, Gong X, Cheng S, et al.

    The Journal of pediatrics 2022; (240()):177-185 doi:10.1016/j.jpeds.2021.09.015.

    PMID: 34543620
  6. 6

    Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).

    Lahoti A, Harris YT, Speiser PW, et al.

    Pediatric blood & cancer 2016; (63(2)):306-12 doi:10.1002/pbc.25780.

    PMID: 26496000
  7. 7

    Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.

    Duncan BB, Lotter JL, Superata J, et al.

    British journal of haematology 2024; (204(5)):2077-2085 doi:10.1111/bjh.19357.

    PMID: 38462764
  8. 8

    Transfusion burden in early childhood plays an important role in iron overload in Diamond-Blackfan anaemia.

    de Wilde JRA, van Dooijeweert B, van Vuren AJ, et al.

    EJHaem 2022; (3(4)):1300-1304 doi:10.1002/jha2.524.

    PMID: 36467824
  9. 9

    Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload.

    Yui JC, Geara A, Sayani F

    Vox sanguinis 2021; (116(7)):793-797 doi:10.1111/vox.13064.

    PMID: 33529394
  10. 10

    Moxibustion with deferasirox results in safe, accelerated, and sustained cardiac iron chelation for a young Diamond Blackfan Anemia patient: An integrative case report.

    Marie EF

    Explore (New York, N.Y.) 2021; (17(3)):239-246 doi:10.1016/j.explore.2020.05.011.

    PMID: 32622815
  11. 11

    Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.

    Papneja K, Bhatt MD, Kirby-Allen M, et al.

    Pediatric blood & cancer 2016; (63(8)):1480-3 doi:10.1002/pbc.25995.

    PMID: 27082377
  12. 12

    Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.

    Behfar M, Koochakzadeh L, Yazdanian N, et al.

    The Turkish journal of pediatrics 2019; (61(3)):407-412.

    PMID: 31916719
  13. 13

    Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia.

    Strahm B, Loewecke F, Niemeyer CM, et al.

    Blood advances 2020; (4(8)):1760-1769 doi:10.1182/bloodadvances.2019001210.

    PMID: 32343795
  14. 14

    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.

    Diaz-de-Heredia C, Bresters D, Faulkner L, et al.

    Bone marrow transplantation 2021; (56(12)):2956-2963 doi:10.1038/s41409-021-01449-w.

    PMID: 34462566
  15. 15

    Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT).

    Miano M, Eikema DJ, de la Fuente J, et al.

    Transplantation and cellular therapy 2021; (27(3)):274.e1-274.e5 doi:10.1016/j.jtct.2020.12.024.

    PMID: 33781541
  16. 16

    Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes?

    Hudda Z, Myers KC

    Hematology. American Society of Hematology. Education Program 2023; (2023(1)):141-148 doi:10.1182/hematology.2023000471.

    PMID: 38066882
  17. 17

    Pediatric diamond-blackfan anemia after hematopoietic stem cell transplantation complicated by bronchiolitis obliterans and air-leak syndrome leading to lung transplantation: a case report with multimodal follow-up.

    Zhang W, Zhao Y, Ge N, et al.

    Frontiers in immunology 2026; (17()):1782188 doi:10.3389/fimmu.2026.1782188.

    PMID: 42099653

This page is for informational purposes only and does not constitute medical advice. Your child's pediatric hematology team should tailor steroid, transfusion, iron-chelation, and transplant decisions to your child's needs.

Get notified when new evidence is published on Pure red-cell aplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.